SAM
RMD icon

Sawgrass Asset Management’s ResMed RMD Stock Holding History

Sawgrass Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.11M Buy
22,742
+21,760
+2,216% +$5.42M 0.77% 39
2025
Q4 		$237K Hold
982
– – 0.03% 169
2025
Q3 		$269K Buy
+982
New +$268K 0.03% 164

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sawgrass Asset Management's RMD Position: Q1 2026 in Review

Sawgrass Asset Management increased its ResMed (RMD) stake by 2,216% in Q1 2026, buying an estimated $5.42M and bringing the position to 22,742 shares worth $5.11M. The position accounts for 0.77% of the portfolio, ranked #39.

Sawgrass Asset Management first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Sawgrass Asset Management held 22,742 shares of ResMed worth $5.11M as of Q1 2026.
  • Sawgrass Asset Management bought 21,760 ResMed shares in Q1 2026, an estimated $5.42M.
  • ResMed made up 0.77% of Sawgrass Asset Management's portfolio in Q1 2026, its #39 holding.
  • Sawgrass Asset Management first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Sawgrass Asset Management's 13F filing for Q1 2026, filed 1 May 2026.